MDS Pharma Services' Global Central Lab to launch Apollo
22 Gennaio 2008 - 2:00PM
PR Newswire (US)
A proprietary web-based study management system KING OF PRUSSIA,
PA, Jan. 22 /PRNewswire-FirstCall/ -- MDS Pharma Services, a
leading provider of innovative drug discovery and development
solutions, announced today the launch of its proprietary Apollo
study management system developed for its Global Central Lab
business. Designed with valuable input from clients, Apollo is a
unified, web-based study management tool for secure and transparent
tracking of study samples and results. Apollo gives clients
real-time, worldwide access to their study data virtually anywhere,
anytime. The system strengthens the "chain of custody" - from
specimen collection to central lab receipt, to testing and sample
storage - further improving the efficiency and quality of studies
managed by MDS Pharma Services. And because the system is
accessible virtually anywhere, anytime, it will enable MDS Pharma
Services to respond quickly to changes in client needs and study
requirements regardless of where the client is or where the work is
being done. Apollo provides a single interface for all aspects of
protocol management, including protocol specifications, kit
building, sample reception and test ordering, query identification
and resolution, customizable results flagging, report distribution,
frozen sample management, data extraction and invoicing. The
experience for clients using Apollo will be consistent whether the
work is being done in MDS sites in China, Singapore, France,
Germany, Canada or the US. "The Apollo system offers significant
benefits to our customers, both in terms of efficiency and
standardization in study management," said MDS Pharma Services
President, David Spaight. "A single, global system with increased
transparency of processes and data across all our sites will help
us consistently deliver on our brand promise of quality, on-time
results. And the Apollo system - which is exclusive to MDS Pharma
Services - will help to redefine the customer experience allowing
studies to start on time, run smoothly and end on time." Based on
input from client surveys, beta testing, and Lean Sigma process
improvement initiatives at MDS Pharma Services, the Apollo system
was specifically designed to provide real-time, worldwide access to
data. It enables single study setup and supports MDS Pharma
Services' core competencies, operating procedures and standards.
Built on an Oracle database, the Apollo system is a truly singular
database that replaces multiple legacy systems and sub-systems,
helping to drive improvements in efficiency and quality across the
central laboratory business. Apollo provides for global
standardization of requisitions, reports, kits, barcode labels, as
well as scientific information, and improves the accuracy and speed
of sample reception and processing. The new system provides client
study teams a host of features that enable greater control over all
aspects of the study. These features include: - A dashboard for
high-level overview of a trial, including automated kit expiry and
test cancellation notification, alert/exclusion reports and query
notices regarding pre-programmed escalations. - Automatic detection
of late or missing batch samples, third-party shipping list
templates, automatic recall site notification, recall of frozen
samples from affiliate laboratories and global frozen sample
inventory reports. - Kit building support, including latest bills
of material, kit component inventories with specific lot numbers
and expiry dates and pre-labeled tubes for delivery to study sites.
About MDS Pharma Services MDS Pharma Services is committed to
delivering quality results on time. We offer a full spectrum of
resources to meet the drug discovery and development needs of the
pharmaceutical and biotechnology industries. With numerous
facilities strategically located around the world, we apply
advanced scientific and technological expertise throughout the drug
discovery and development process - from lead optimization, pre-IND
research, early clinical research (bioequivalence, phases I-IIa)
and bioanalysis through to global clinical development (phases
IIb-IV), central lab and centralized cardiac services. For more
information, visit our website at http://www.mdsps.com/. MDS Pharma
Services is a business unit of MDS Inc. (TSX: MDS; NYSE: MDZ), a
global life sciences company that provides market-leading products
and services that our customers need for the development of drugs
and diagnosis and treatment of disease. We are a leading global
provider of pharmaceutical contract research, medical isotopes for
molecular imaging, radiotherapeutics, and analytical instruments.
MDS has more than 5,500 highly skilled people in 28 countries. Find
out more at http://www.mdsinc.com/ or by calling 1-888-MDS-7222, 24
hours a day. DATASOURCE: MDS Pharma Services CONTACT: For
Investors: Sharon Mathers, (416) 675-6777 ext. 4721, ; For Media:
Charlene McGrady, (610) 239-7900 ext. 231,
Copyright